GGrantIndex
← Leaderboards

Navid Khodaparast

Spark Biomedical Inc

$6,107,273
Attributed
$12,971,370
Total exposure
6
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $4.4M · FY201925
$5M$3.8M$2.5M$1.3M$0
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$12,971,370 · 6

By mechanism

RM1$7,138,197 · 1
R44$4,991,063 · 2
R43$536,565 · 2
R41$305,545 · 1

Others in their field

Other Emerging Leaders on “Opioid

Research focus

OpioidWithdrawal SymptomOpioid WithdrawalDevicesPharmaceutical PreparationsAcuteAdultSparrowsNeonateOpioid EpidemicOpioid UseNerveSuccessTrigeminal SystemPharmacotherapyMorphinePainCranial NervesClinical ResearchPersonsNeuroregulationNon-Opioid AnalgesicDouble-Blind MethodChronic Pain

Grant awards (11)

Understanding the Mechanistic, Neurophysiological, and Antinociceptive Effects of Transcutaneous Auricular Neurostimulation for Treatment of Chronic Pain$1,733,153
RM1 · FY2025 · NS
Study of Transcutaneous Auricular Neurostimulation as a Treatment for Alcohol Use Disorder$305,545
R41 · FY2025 · AA · contact PI
Understanding the Mechanistic, Neurophysiological, and Antinociceptive Effects of Transcutaneous Auricular Neurostimulation for Treatment of Chronic Pain$1,753,199
RM1 · FY2024 · NS
Development of a Machine Learning Algorithm to Detect Opioid Withdrawal and Cravings to Increase Treatment Retention$318,875
R43 · FY2024 · DA · contact PI
Understanding the Mechanistic, Neurophysiological, and Antinociceptive Effects of Transcutaneous Auricular Neurostimulation for Treatment of Chronic Pain$1,741,775
RM1 · FY2023 · NS
Understanding the Mechanistic, Neurophysiological, and Antinociceptive Effects of Transcutaneous Auricular Neurostimulation for Treatment of Chronic Pain$1,910,070
RM1 · FY2022 · NS
Delivering Transcutaneous Auricular Neurostimulation as an Adjunct Treatment for Neonatal Opioid Withdrawal Syndrome$1,248,001
R44 · FY2022 · DA · contact PI
Delivering Transcutaneous Auricular Neurostimulation to Improve Treatment Retention in Opioid Use Disorder$1,246,700
R44 · FY2022 · DA · contact PI
Delivering Transcutaneous Auricular Neurostimulation as an Adjunct Treatment for Neonatal Opioid Withdrawal Syndrome$1,249,662
R44 · FY2021 · DA · contact PI
Delivering Transcutaneous Auricular Neurostimulation to Improve Treatment Retention in Opioid Use Disorder$1,246,700
R44 · FY2021 · DA · contact PI
Transcutaneous auricular neurostimulation for neonatal abstinence syndrome$217,690
R43 · FY2019 · DA · contact PI